Effects of KT-210 (nipradilol ophthalmic solution) on blood pressure and heart rate in the anesthetized dog

Japanese Pharmacology and Therapeutics

Volumn 24, Issue SUPPL. 8, 1996, Pages 49-52

  Mizuno, Ken ^a  

^a KOWA COMPANY LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS; NIPRADILOL;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOG; DRUG EFFECT; HEART RATE; NONHUMAN; TOPICAL DRUG ADMINISTRATION;

EID: 0029799837     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Quigley HA : Open-angle glaucoma. N Engl J Med 328 : 1097-1106, 1993
2. Katz IM et al : Intraocular pressure decrease in normal volunteers following timolol ophthalmic solution. Invest Ophthalmol 15 : 489-492, 1976
3. Brooks AMV, Gilles WE : Ocular β-blockers in glaucoma management ; Clinical pharmacological aspects. Drugs and Aging 2 : 208-221, 1992
4. Radius RL et al : A new drug for management of chronic simple glaucoma. Arch Ophthalmol 96 : 1003-1008, 1978
5. Scoville B et al : A double-masked comparison of carteolol and timolol in ocular hypertension. Am J Ophthalmol 105 : 150-154, 1988
6. Uusitalo RJ, Palkama A : Long-term evaluation of timolol. Acta Ophthalmologica 67 : 573-581, 1989
7. Boger III WP et al : Long-term experience with timolol ophthalmic solution in patients with open-angle glaucoma. Ophthalmol 85 : 259-267, 1978
8. Keates EU : Evaluation of timolol maleate combination therapy in chronic open-angle glaucoma. Am J Ophthalmol 88 : 565-571, 1979
9. 2-adrenoceptor inhibition. Clin Pharmacol Ther 47:578-583, 1990
10. Hugues FC et al : Effects of β-adrenoceptors blocking eye drops in patients with chronic bronchitis. Therapie 47 : 211-215, 1992
11. Nelson WL et al : Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985. Am J Ophthalmol 102 : 606-611, 1986
12. Uchida Y et al : Vasoactive and β-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino)propoxy-3-nitroxy-2 H-1-benzopyran (K-351) a new antihypertensive agent. Arch int Pharmacodyn 262 : 132-149, 1983
13. Coakes RL, Blubaker RF : The mechanism of timolol in lowering intraocular pressure in the normal eye. Arch Ophthalmol 96 : 2045-2048, 1978
14. Akers MJ et al : Practical aspects of ophthalmic drug development. Drug Development and Industrial Pharmacy 3 : 185-217, 1977
15. Shell JW : Pharmacokinetics of topically applied ophthalmic drugs. Surv Ophthalmol 26 (4) : 207-218, 1982
16. Scriabine A et al : Some cardiovascular effects of timolol a newβ-adrenergic blocking agent. Arch int Pharmacodyn 205 : 76-93, 1973